Stoke Therapeutics, Inc. Other Current Assets
Stoke Therapeutics, Inc. (STOK) had Other Current Assets of $6.31 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-08-03
- 2026-06-30: Other Assets, Current $6.31M.
- 2026-03-31: Other Assets, Current $6.88M.
- 2025-12-31: Other Assets, Current $4.39M; Other Assets, Current as first filed $3.90M.
- 2025-09-30: Other Assets, Current $5.54M.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $6.31M 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $6.88M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $4.39M 10-Q · filed 2026-08-03 | $3.90M 10-K · filed 2026-03-16 |
| 2025-09-30 | $5.54M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $6.87M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $5.04M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $2.30M 10-K · filed 2026-03-16 | $3.96M 10-K · filed 2025-03-18 |
| 2024-09-30 | $3.81M 10-Q · filed 2024-11-05 | |
| 2024-06-30 | $4.29M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $3.56M 10-Q · filed 2024-05-06 | |
| 2023-12-31 | $2.56M 10-K · filed 2025-03-18 | |
| 2023-09-30 | $4.27M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $3.70M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $5.88M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $2.96M 10-K · filed 2024-03-25 | |
| 2021-12-31 | $2.22M 10-K · filed 2023-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |